186
Participants
Start Date
April 30, 2014
Primary Completion Date
March 5, 2018
Study Completion Date
March 5, 2018
Botulinum toxin type A
"This is an observational study designed to reflect the clinical practice in real life as closely as possible.~Botulinum Toxin Type A (BoNT-A) injection administered according to the local Summary of Product Characteristics (SmPC) and the locally agreed treatment guidelines."
Hospital Marítimo Oza, A Coruña
Hospital General de Albacete, Albacete
Hospital de Basurto, Bilbao
Hospital de Cruces, Bilbao
Hospital de Galdácano, Bilbao
Hospital Gorliz, Bilbao
Hospital Guadalajara, Guadalajara
Hospital Dr Negrín, Las Palmas de Gran Canaria
Hospital Insular, Las Palmas de Gran Canaria
Hospital San Pedro, Logroño
Fundación Jimenez Díaz, Madrid
Hospital 12 Octubre, Madrid
Hospital Alcorcón, Madrid
Hospital General de Móstoles, Madrid
Hospital Principe de Asturias de Alcalá de Henares, Madrid
Hospital Universitario de la Princesa, Madrid
Hospital Ourense, Ourense
Hospital Son Espases, Palma de Mallorca
Clinica Ubarmin, Pamplona
Hospital Virgen de la Vega, Salamanca
Hospital de Donosti, San Sebastián
Hospital de la Candelaria, Santa Cruz de Tenerife
Hospital Universitario Canarias, Santa Cruz de Tenerife
Hospital Virgen de la Salud, Toledo
Hospital Reina Sofía, Tudela
Hospital Clinico Valladolid, Valladolid
Hospital Xeral de Vigo, Vigo
Hospital Universitario de Alaba, Vitoria-Gasteiz
Lead Sponsor
Ipsen
INDUSTRY